Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

End-of-phase II meeting for Puricase

Aug. 2, 2005

Kyoto University discloses novel therapeutic agents for eating disorders

July 29, 2005

Melanocortin MC4 receptor agonists in early development at Novo Nordisk

July 29, 2005

NDA accepted for Wyeth's new oral contraceptive

July 29, 2005

Tempol improves dopamine D1 receptor dysfunction in obese rats

July 29, 2005

Preclinical evidence suggests estrogen receptors play a role in gonadotropin-induced fertility

July 29, 2005

Ruboxistaurin reduces vision loss risk in patients with diabetic retinopathy

July 28, 2005

FDA issues public health advisory for mifepristone

July 27, 2005

In vitro and in vivo effects of novel DPP-IV inhibitor KR-62436

July 27, 2005

MC4 receptor agonist shows in vivo efficacy for obesity and sexual dysfunction

July 27, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...